INSR and type 1 diabetes mellitus: This was further supported by our data showing significant T1D progression (60% T1D onset; Figure 2A, green solid line) of mice treated with Nap‐GdFdAdY, as it lacks the two phenylalanines that are essential for insulin receptor interaction.